Untargeted Metabolomics and Liquid Biopsy Investigation of Circulating Biomarkers in Soft Tissue Sarcoma
Choline decrease emerged as a marker for cancer progression, highlighting the potential of targeting its metabolism for therapeutic approaches in STS. The NMR analysis protocol proved effective for determining circulating biomarkers from liquid biopsies, making it suitable for rare disease research.
Authors
- Lorenzo Antonuzzo (ORCID: https://orcid.org/0000-0003-3349-5604)
- Domenico Andrea Campanacci (ORCID: https://orcid.org/0000-0002-3912-3943)
- Federico Scolari (ORCID: https://orcid.org/0000-0001-5490-672X)
- Barbara Marzocchi (ORCID: https://orcid.org/0000-0002-4622-7054)
- Daniela Grasso (ORCID: https://orcid.org/0000-0001-7708-9339)
- Ilaria Palchetti (ORCID: https://orcid.org/0000-0001-9366-0574)
- Guido Scoccianti (ORCID: https://orcid.org/0000-0003-0637-6896)
- Andrea Bernini (ORCID: https://orcid.org/0000-0002-7528-2749)
- Serena Pillozzi (ORCID: https://orcid.org/0000-0001-8861-8718)
Institutions
- University of Siena (IT)
- Azienda Ospedaliero-Universitaria Careggi (IT)
- University of Florence (IT)
Publication Details
- Journal
- Cancers
- Published
- 2025-02-06
- DOI
- https://doi.org/10.3390/cancers17030553
- Citations
- 3
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 2.81
Funders
- Regione Toscana